Originally posted by GenoMax
View Post
-
@Yangan: Since your CLC license includes free tech support you may want to contact them about this question (I assume you want to do this within CLC). They may need to provide you with a plugin or custom code to do the action you are referring to.Leave a comment:
-
How to extract nucleotide sequeces from tblastx table
Hi there,
I am a new learner of bioinformatics.
I used Trinity to do de novo transcriptome assembly then imported the assembly.fasta file into CLC genomeworkbench 7.0.3 to run tblastx using this assembly file as local database while using all P450 cDNA of Arabidopsis as queries. Next step I would like to map reads to these contigs with hits. However, I don't know how to seive all the contigs with hits (nucleotide sequences) out after using tblastx since all sequences were translated in to amino acid sequences.
I tried "Toolbox-Classical Sequence Analysis-General Sequence Analysis-Extract sequence", but only amino acid sequences were obtained. I could also extract the nucleotide sequence of a single contig every time, but there are thousands of contigs with hits in my case.
Anyone knows how to achieve that?
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Leave a comment: